Cargando…
Why was GOG-0213 a negative trial?
Autores principales: | Ehmann, Sarah, Zivanovic, Oliver, Chi, Dennis S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767651/ https://www.ncbi.nlm.nih.gov/pubmed/33300314 http://dx.doi.org/10.3802/jgo.2021.32.e19 |
Ejemplares similares
-
The value of secondary neoadjuvant chemotherapy in platinum-sensitive recurrent ovarian cancer: a case-control study post GOG-0213 trial
por: Gu, Hongyuan, et al.
Publicado: (2020) -
Future of translational research: Why go pragmatic?
por: Jazieh, Abdul Rahman
Publicado: (2011) -
Alzheimer’s Disease – Why We Need Early Diagnosis
por: Rasmussen, Jill, et al.
Publicado: (2019) -
Beyond Dual Bronchodilation – Triple Therapy, When and Why
por: Cazzola, Mario, et al.
Publicado: (2022) -
Vascular aging and subclinical atherosclerosis: why such a “never ending” and challenging story in cardiology?
por: Iurciuc, Stela, et al.
Publicado: (2017)